Melanie Whittington

Melanie (Mel) Whittington is a Managing Director and Head of the Center for Pharmacoeconomics where she leads efforts to evaluate the health and economic impacts of healthcare innovations in the United States. She offers insight and perspective on the evidence needed to support strong health economic value propositions and the potential impact of novel cost-effectiveness analysis frameworks. As a thought leader in health economics, she provides commentary on health system efficiency, incentives for innovation, and the evolving landscape of drug pricing. She also hosts the Perspectives by the Leerink Center for Pharmacoeconomics podcast.

Dr. Whittington is also a Senior Fellow within the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center, is on the Panel of Health Advisers for the Congressional Budget Office, and is an Advisory Board member for the Incubate Coalition. She has published more than 70 peer-reviewed articles.

Prior to joining MEDACorp in 2024, Dr. Whittington was the Managing Director and Founder of Valusphere, a health economics consultancy that developed economic evaluations, advised on value demonstration, and provided training to value assessment stakeholders. Prior to Valusphere, Dr. Whittington was the Director of Health Economics at the Institute for Clinical and Economic Review and was faculty within the School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus.

Dr. Whittington earned a BS in Biological Sciences from the University of Missouri, an MS in Health Sciences from Western Illinois University, and a PhD in Health Services Research from the University of Colorado Anschutz Medical Campus.